Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Aug 26, 2026
Reporting period
Not applicable
Filed with the SEC
Aug 27, 2026
DirectorOption exercise
Context
Classification
option exercise
Code M — exercise or conversion of a derivative security
Planned / mechanical clue
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001213307-26-000005
Filed / recorded
Aug 27, 2026, 10:44 PM UTC
Added to OQRO
Oct 2, 2026, 12:27 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
GILEAD SCIENCES, INC.
Issuer CIK
882095
Ticker
GILD
Reporting person
Anthony Welters
Relationship
Director
Security
Non-qualified Stock Option (Right to Buy)
Table
Derivative (Table II)
Transaction date
Aug 26, 2026
Transaction code
M
Shares / units
10,282
Price per share
$0.00
Acquired / disposed
Disposed (D)
Shares owned after
5,569
Ownership form
Direct
Amendment
No
Footnotes from the filing
The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2026.
25% of the shares subject to the option vested on each three-month anniversary measured from October 22, 2020 such that 100% of the shares subject to the option were fully vested and exercisable on October 22, 2021.